Key Metrics
CiteScore 

13.6
Eigenfactor 

0.01 - 0.05
Impact Factor 

5 - 10
SJR 

Q1Biotechnology

SNIP 

1.19
Recommended pre-submission checks
Powered by 

Topics Covered on Artificial Cells, Nanomedicine and Biotechnology
Artificial Cells, Nanomedicine and Biotechnology Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | TAYLOR & FRANCIS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | GBP 2085 |
| Publication Time | 20 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2013 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Artificial Cells, Nanomedicine and Biotechnology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Artificial Cells, Nanomedicine and Biotechnology
Mechanism by which Qingre Lishi formula regulates Behçet’s disease through gut microbiota-derived metabolites
- 31 Dec 2026
- Artificial Cells, Nanomedicine, and Biotechnology
Green synthesis of ZnO nanoparticles using pomegranate husk extract: comparative evaluation of antioxidant, enzyme inhibition, and cytotoxic properties
- 31 Dec 2026
- Artificial Cells, Nanomedicine, and Biotechnology
Anticancer activity of fluoxetine Janus dendrimer against cancer cells
- 31 Dec 2026
- Artificial Cells, Nanomedicine, and Biotechnology
AI-guided data-driven kinetic modelling carbon quantum dot-enabled pH-responsive CMC/CeO2 nanocarriers for quercetin delivery and in vitro evaluation in lung cancer cells
- 31 Dec 2026
- Artificial Cells, Nanomedicine, and Biotechnology
Detection of pathogenic novel intronic splicing variants in the KIDINS220 gene causes motor developmental delay
- 31 Dec 2026
- Artificial Cells, Nanomedicine, and Biotechnology
Real-time RNA sensors for diabetes management: assessing the impact of endocrine disruptors on biosensing and point-of-care diagnostics
- 31 Dec 2026
- Artificial Cells, Nanomedicine, and Biotechnology
Mechanism by which Qingre Lishi formula regulates Behçet’s disease through gut microbiota-derived metabolites
- 31 Dec 2026
- Artificial Cells, Nanomedicine, and Biotechnology
Green synthesis of ZnO nanoparticles using pomegranate husk extract: comparative evaluation of antioxidant, enzyme inhibition, and cytotoxic properties
- 31 Dec 2026
- Artificial Cells, Nanomedicine, and Biotechnology
Anticancer activity of fluoxetine Janus dendrimer against cancer cells
- 31 Dec 2026
- Artificial Cells, Nanomedicine, and Biotechnology
AI-guided data-driven kinetic modelling carbon quantum dot-enabled pH-responsive CMC/CeO2 nanocarriers for quercetin delivery and in vitro evaluation in lung cancer cells
- 31 Dec 2026
- Artificial Cells, Nanomedicine, and Biotechnology
Detection of pathogenic novel intronic splicing variants in the KIDINS220 gene causes motor developmental delay
- 31 Dec 2026
- Artificial Cells, Nanomedicine, and Biotechnology
Real-time RNA sensors for diabetes management: assessing the impact of endocrine disruptors on biosensing and point-of-care diagnostics
- 31 Dec 2026
- Artificial Cells, Nanomedicine, and Biotechnology